Form 4 for BDSX BIODESIX INC
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-13 · accession 0001567619-22-001264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-18 | 2022-01-13 | BDSX | Cowie Robin Harper | CFO, Sec'y, Treas | M - OptEx | $0.42 | +5,679 | 47.7K | +14% | +$2,385 |
| DM | 2022-01-18 | 2022-01-13 | BDSX | Cowie Robin Harper | CFO, Sec'y, Treas | M - OptEx | $0.00 | -5,679 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-13 | M | A | 2,520 | $0.42 | 44,495 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-13 | M | A | 3,159 | $0.42 | 47,654 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2022-01-13 | M | D | 3,159 | $0.00 | 4,210 | D | $0.42 · — to 2028-04-03 | 3,159 Common Stock | (F2) This option vests in 60 successive, equal monthly installments measured from January 1, 2018. |
| 4 | Derivative | Stock Options (Right to buy) | 2022-01-13 | M | D | 2,520 | $0.00 | 0 | D | $0.42 · — to 2027-05-15 | 2,520 Common Stock | (F1) This option vested in 60 successive, equal monthly installments measured from January 1, 2017. |